science-based regulation

In one of the most consequential institutional changes at the EPA in decades, Deputy Administrator David Fotouhi announced in an internal memo that the EPA will no longer use the Integrated Risk Information System (IRIS) program to develop c
Lars began by emphasizing the urgency of advancing biotechnology safely. I reassured him that this is possible, highlighting two key factors: aggressive private sector investment, federally funded basic research, and science-based regulation.